Page last updated: 2024-10-30

meprobamate and Pelvic Inflammatory Disease

meprobamate has been researched along with Pelvic Inflammatory Disease in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gitsch, E1

Other Studies

1 other study available for meprobamate and Pelvic Inflammatory Disease

ArticleYear
[The therapy of gynecologic endocrine disorders through autonomic nervous active materials].
    Acta neurovegetativa, 1967, Volume: 30, Issue:1

    Topics: Endocrine Glands; Female; Humans; Menopause; Meprobamate; Metrorrhagia; Parasympatholytics; Pelvic I

1967